Robocath announces completion of first robotic coronary angioplasty with R-One in China
Ngày 01/12/2021 09:34 | Lượt xem: 786

Robocath has announced the successful completion of what it has described as the first coronary angioplasty in China assisted by its R-One robotic platform. The procedure took place at the 301 Hospital in Beijing on 24 November, performed by Yundai Chen.

This robotic assisted procedure is the first intervention within a clinical study carried out by CathBot; a joint venture between Robocath and MedBot (the robot-focused subsidiary of MicroPort Scientific Corporation). This clinical study will include over 100 patients, across four centers with a goal to obtain marketing authorisation for the R-One robotic platform in China, via the National Medical Products Administration (NMPA).

Chen said: “Robocath’s robotic platform enables a coronary angioplasty to be carried out safely, whilst being totally protected from radiation, and under more comfortable conditions. It is intuitive and the system is incredibly precise; it’s possible to position stents to the exact millimetre. I am flattered to have been the first person to use this technology in China and to help push forward the progress of robotics in our country.”

He Chao, president of MedBot, said: “This first clinical trial of a robotic PCI with R-One is an important milestone in the surgical robotics field for our company. There is no similar product available in our country. With the clinical development and subsequent launch of R-One, it will fill the field gap in robotic PCI in China and will benefit both doctors and patients.”

Philippe Bencteux, president and founder of Robocath and president of CathBot, outlined: “We have reached a key step in our product development, in accordance with our development plan, in a highly strategic geographical area. China currently carries out more angioplasties than any other country. I’d like to thank the CathBot teams for all their work. Together, with our remote treatment technology, our robot will eventually become a key element in access to patient care within the country.”

Lucien Goffart, Robocath’s CEO, added: “In the interventional cardiology field, the Chinese market currently has the highest growth rate in the world. More than a million procedures per year are performed in the country and the number of catheterization labs has doubled since 2010—now reaching 2,000. This procedure comes only one year after the joint venture setup; it marks a key step in its development. This puts us in a strong position to be awarded marketing authorisation from the NMPA in the near future.”

Source CardiovascularNews

Duc Tin Clinic

Print Chia sẽ qua facebook bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua google bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua twitter bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua MySpace bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua LinkedIn bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua stumbleupon bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua icio bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua digg bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua yahoo bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua yahoo bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua yahoo bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China Chia sẽ qua yahoo bài: Robocath announces completion of first robotic coronary angioplasty with R-One in China

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP